Doctors have been warned not to give the anti-depressant Seroxat to women in the first three months of pregnancy as it could increase the risk of abnormalities in babies. A study by the manufacturers of the drug, GlaxoSmithKline, suggests that the risk of fetal problems such as heart defects may be higher among women taking Seroxat. A spokesman for the company said: "The current product information states that Seroxat (paroxetine) should be used during pregnancy only when strictly indicated. Doctors are advised to carefully weigh the potential risks and benefits of using paroxetine therapy in women during pregnancy." [The Telegraph, 29 September]
To subscribe to SPUC's email information services, please visit www.spuc.org.uk/em-signup. The reliability of the news herein is dependent on that of the cited sources, which are paraphrased rather than quoted. Opinions expressed are not necessarily those of the society. © Society for the Protection of Unborn Children, 2012